Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Psychoneuroimmunology: Diabetes and Cancer

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Integration of donor microbiota following FMT correlates with anti-PD-1 response in melanoma.

Nature communications·2026

Same author

Erythropoietin receptor on cDC1s dictates immune tolerance.

Nature·2025

Same author

Reflections on Advances in Cancer Research in 2025.

Cancer discovery·2025

Same author

Mitochondria redistribution organizes the immunosuppressive tumor ecosystem.

bioRxiv : the preprint server for biology·2025

Same author

Lymph node environment drives FSP1 targetability in metastasizing melanoma.

Nature·2025

Same author

Spontaneous and experimental models of lymph node metastasis.

Nature protocols·2025

Same journal

SqueakPose Studio, an end-to-end platform for pose estimation and real-time edge-AI deployment.

eLife·2026

Same journal

Mechanistic insights into transcriptional regulation of ARHGAP36 expression identify a factor predictive of neuroblastoma survival.

eLife·2026

Same journal

Activity-dependent CO<sub>2</sub> production in the axon triggers opening of Connexin32 in the Schwann cell paranode.

eLife·2026

Same journal

Lipid packing contributes to the confinement of caveolae to the plasma membrane.

eLife·2026

Same journal

A coma pattern-based autofocusing method resolves bacterial cold shock response at single-cell level.

eLife·2026

Same journal

Non-canonical amino acid incorporation enables minimally disruptive labeling of stress granule and TDP-43 proteinopathy.

eLife·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 15, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

Cancer systems immunology.

Nathan E Reticker-Flynn¹, Edgar G Engleman^1,2,3

¹Department of Pathology, Stanford University School of Medicine, Stanford, United States.

|July 14, 2020

Summary

This summary is machine-generated.

Cancer Systems Immunology integrates advanced -omics technologies and computational tools to study complex tumor-immune interactions. This emerging field promises to deepen our understanding of tumor immunology and advance cancer immunotherapy strategies.

Keywords:

cancer biology cancer systems biology immunology inflammation systems biology systems immunology tumor immunology tumor immunotherapy

More Related Videos

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Experiment Videos

Last Updated: Dec 15, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Area of Science:

Oncology
Immunology
Computational Biology
Systems Biology

Background:

Tumor immunology is rapidly advancing, driven by successful cancer immunotherapies.
The development of -omics technologies has provided powerful new tools for biological research.

Purpose of the Study:

To apply systems biology approaches to understand the complex interactions between tumors and the immune system.
To leverage computational and modeling toolsets for analyzing multivariate biological data in cancer.

Main Methods:

Utilizing advanced -omics technologies (genomics, proteomics, etc.).
Employing computational and mathematical modeling techniques.
Interrogating multi-scale, multi-system biological interactions.

Main Results:

The nascent field of Cancer Systems Immunology is already enhancing the understanding of tumor immunology and immunotherapy.
Systems biology approaches are well-suited to dissect the complexity of tumor-immune interactions.

Conclusions:

Cancer Systems Immunology holds significant promise for advancing cancer treatment.
Future research will focus on functional investigations of emergent behaviors in tumor-immune responses.